At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 380 enrolled
Drug / intervention
Saline +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MIRs03: A Double-blind Randomized Trial of Paravertebral Block With Ropivacaine Before Breast Cancer Surgery: Effects on Chronic Postoperative Pain
In Brief
A Phase 3 clinical trial evaluating Saline and Ropivacaine for Malignant Neoplasm of Breast. Completed, enrolled 380 participants across 6 sites.
Detailed Summary
Compare the effect of paravertebral block (PVB) with Ropivacaine or placebo on the incidence of chronic pain 3 months after breast cancer surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalignant Neoplasm of Breast
CountriesFrance
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartMar 2015
First PostedApr 2015
Primary CompletionJul 2018
Study CompletionMar 2019
TodayJul 2026
First PostedApr 3, 2015
Enrollment StartMar 27, 2015
Primary CompletionJul 1, 2018
Study CompletionMar 9, 2019
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 11.2 years ago
Interventions
Salinedrug
Ropivacainedrug